Search results
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
Zacks via Yahoo Finance· 2 days agoThe sales contribution of Iovance’s other marketed cancer drug, Proleukin, is not likely to be...
Teva Pharma's Turnaround Story: How A Key Win Helped It Clinch A Five-Year High
Investor's Business Daily· 2 hours agoAnd revenue from migraine prevention drug Ajovy surged almost 20% to $113 million. Teva also...
FTC Moves to Allow Generic Versions of Ozempic
Futurism via Yahoo Finance· 5 days agoThe Federal Trade Commission is seeking to clear the path for generic Ozempic — but there will be a long road ahead before cheaper versions of the...
Dr. Reddy's (RDY) Q4 Earnings Top, North America Sales Grow
Zacks· 17 hours agoDr. Reddy's (RDY) posts better-than-expected fiscal fourth-quarter results on growth in global generics revenues in North America as well as Emerging Markets.
Bausch Health (BHC) Q1 Earnings and Revenues Miss Estimates
Zacks· 7 days agoThis quarterly report represents an earnings surprise of -21.33%. Over the last four quarters, the company has surpassed consensus EPS estimates three times. , which belongs ...
Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand
Zacks via Yahoo Finance· 1 day agoThis, in turn, prompts collaboration deals with either pharma or biotech bigwigs, wherein sales are...
GSK knew about Zantac cancer risk, attorneys tell jury in first trial
StreetInsider· 6 days agoMikal Watts, who is representing 89-year-old Angela Valadez, said the companies knew that Zantac’s active ingredient, ranitidine, would turn into a cancer-causing substance called NDMA as it ...
India's Dr Reddy's expects healthy products pipeline in North America for FY25
Reuters· 1 day ago, opens new tab expects a healthy products pipeline in its key North American market in the fiscal year 2024-25, the generic drugmaker said on Tuesday, after it reported a ...
Undervalued by 28%, This Stock Is a Buy for Patient Investors
Morningstar· 5 hours agoBiogen appeared on our list of 10 undervalued wide-moat stocks to buy several weeks ago. It’s also...
Bausch Health investors are left in a holding pattern as 2 major overhangs remain unresolved
CNBC· 6 days agoBausch Health Companies on Tuesday morning reported first-quarter top- and bottom-line misses —...